Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

27.05.2024

8 Ann Intern Med
5 Antiviral Res
1 Biochem Biophys Res Commun
1 Biochemistry
2 BMC Pediatr
13 BMJ
2 Epidemiol Infect
2 J Immunol
2 J Infect
2 J Virol
5 JAMA
9 Lancet
2 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 PLoS Comput Biol
1 PLoS Med
31 PLoS One
4 Proc Natl Acad Sci U S A
22 Vaccine
1 Virus Res


    Ann Intern Med

  1. KEUTE K
    Healing the Sick: A Timeline of Altruism.
    Ann Intern Med. 2024;177:686-687.
    >> Share

  2. CHOW EJ, Lynch JB, Zerr DM, Riedo FX, et al
    Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities.
    Ann Intern Med. 2024;177:689.
    >> Share

  3. IORIO A, Laine C
    What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence.
    Ann Intern Med. 2024;177.
    >> Share

  4. ALHAMMADI A, Alshawaf R, Chavda S, Ramondino S, et al
    Infectious Diseases: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0679.
    >> Share

  5. COSCHI CH, Dodbiba L, Guerry D
    Oncology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
    >> Share

  6. ALHABOBI AAM, Almutairi AMS, Bohemid DASY, Sehgal AR, et al
    Nephrology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0605.
    >> Share

  7. RADCLIFFE C, Kotton CN
    En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era.
    Ann Intern Med. 2024 Apr 9. doi: 10.7326/M24-0256.
    >> Share

  8. WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al
    Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
    >> Share


    Antiviral Res

  9. LIU X, Wang Y, Sun L, Xiao G, et al
    Screening and optimization of shark nanobodies against SARS-CoV-2 Spike RBD.
    Antiviral Res. 2024 Apr 29:105898. doi: 10.1016/j.antiviral.2024.105898.
    >> Share

  10. ARDUINO I, Francese R, Civra A, Feyles E, et al
    Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
    Antiviral Res. 2024;226:105897.
    >> Share

  11. GLITSCHER M, Benz NI, Sabino C, Murra RO, et al
    Inhibition of Pim kinases triggers a broad antiviral activity by affecting innate immunity and via the PI3K-Akt-mTOR axis the endolysosomal system.
    Antiviral Res. 2024;226:105891.
    >> Share

  12. GUO M, Peng J, Guo P, Wang Q, et al
    Inhalation of 2, 4-di-tert-butylphenol-Loaded micelles suppresses respiratory syncytial virus infection in mice.
    Antiviral Res. 2024;226:105880.
    >> Share

  13. TOLKSDORF B, Heinze J, Niemeyer D, Rohrs V, et al
    Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses.
    Antiviral Res. 2024 Apr 8:105879. doi: 10.1016/j.antiviral.2024.105879.
    >> Share


    Biochem Biophys Res Commun

  14. GAUR NK, Urankar S, Sengupta D, Chepuri VR, et al
    A cell based assay using virus-like particles to screen AM type mimics for SARS-CoV-2 neutralisation.
    Biochem Biophys Res Commun. 2024;718:150082.
    >> Share


    Biochemistry

  15. PETERSON JM, Becker ST, O'Leary CA, Juneja P, et al
    Structure of the SARS-CoV-2 Frameshift Stimulatory Element with an Upstream Multibranch Loop.
    Biochemistry. 2024;63:1287-1296.
    >> Share


    BMC Pediatr

  16. SARBAZI E, Masoudi N, Mehri A, Esfanjani RM, et al
    Trust in primary health care and COVID-19 vaccine uptake among Iranian pediatric: a web-based cross-sectional survey.
    BMC Pediatr. 2024;24:356.
    >> Share

  17. LI S, Xiao W, Li H, Hu D, et al
    Identification of neurological complications in childhood influenza: a random forest model.
    BMC Pediatr. 2024;24:347.
    >> Share


    BMJ

  18. MURRAY I
    Covid inquiry: What have we learnt about Northern Ireland's response?
    BMJ. 2024;385:q1160.
    >> Share

  19. TORJESEN I
    Sixty seconds on . . . prepping.
    BMJ. 2024;385:q1161.
    >> Share


  20. Seven days in medicine: 15-21 May 2024.
    BMJ. 2024;385:q1130.
    >> Share

  21. BAHRI C
    The untold health toll of voting.
    BMJ. 2024;385:q1060.
    >> Share

  22. LOOI MK
    Bird flu: US confirms second human case in two months.
    BMJ. 2024;385:q1156.
    >> Share

  23. NAKWEYA G
    Severe budget cuts in Kenya will plunge country into health crisis, officials warn.
    BMJ. 2024;385:q1154.
    >> Share

  24. DUNN K, Hamilton Hurwitz H, Toledo JP, Schwaber MJ, et al
    Summary of WHO infection prevention and control guideline for covid-19: striving for evidence based practice in infection prevention and control.
    BMJ. 2024;385:q645.
    >> Share

  25. YASSAIE R
    Doctors who are activists remind and inspire us also to do the work.
    BMJ. 2024;385:q1138.
    >> Share

  26. RIMMER A
    Physician associates must have a named senior doctor supervising them at all times, says BMA.
    BMJ. 2024;385:q1148.
    >> Share

  27. TORJESEN I
    Wastewater management must have greater focus on protecting public health, says report.
    BMJ. 2024;385:q1142.
    >> Share

  28. DYER C
    Infected blood scandal: "Chilling" cover up hid truth for decades, public inquiry finds.
    BMJ. 2024;385:q1139.
    >> Share

  29. MCKEE M
    The Infected Blood Inquiry: we need some honesty and engagement by those in authority.
    BMJ. 2024;385:q1143.
    >> Share

  30. MAHENDRADHATA Y
    Presidential election brings a challenging future for evidence informed health policies in Indonesia.
    BMJ. 2024;385:q1119.
    >> Share


    Epidemiol Infect

  31. LASANDER M, Elo K, Joronen K, Dub T, et al
    Barriers to vaccine acceptance in the adult population of mainland Finland, 2021 - ERRATUM.
    Epidemiol Infect. 2024;152:e79.
    >> Share

  32. BEALE S, Yavlinsky A, Fong WLE, Nguyen VG, et al
    Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.
    Epidemiol Infect. 2024;152:e77.
    >> Share


    J Immunol

  33. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    >> Share

  34. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    >> Share


    J Infect

  35. PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
    Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
    J Infect. 2024;88:106165.
    >> Share

  36. CHUN JY, Jeong SJ, Kim S, Choi S, et al
    Performance of the Galactomannan Test for the Diagnosis of Invasive Pulmonary Aspergillosis using Non-invasive Proximal Airway Samples.
    J Infect. 2024 Apr 17:106159. doi: 10.1016/j.jinf.2024.106159.
    >> Share


    J Virol

  37. KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al
    Host obesity impacts genetic variation in influenza A viral populations.
    J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778.
    >> Share

  38. SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al
    Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
    J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604.
    >> Share


    JAMA

  39. KOJIMA N, Blumberg A, Radcliffe R, Flannery B, et al
    US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses.
    JAMA. 2024 May 21:e2410116. doi: 10.1001/jama.2024.10116.
    >> Share

  40. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    >> Share

  41. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    >> Share

  42. HARRIS E
    CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle.
    JAMA. 2024;331:1615.
    >> Share

  43. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    >> Share


    Lancet

  44. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    >> Share

  45. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    >> Share

  46. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    >> Share

  47. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    >> Share

  48. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    >> Share

  49. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    >> Share


  50. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    >> Share


  51. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    >> Share


  52. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    >> Share


    MMWR Morb Mortal Wkly Rep

  53. CLEMENS T, Moreland B, Mack KA, Thomas K, et al
    Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure - United States, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:467-473.
    >> Share

  54. TUTTLE A, Hughes CM, Dvorak M, Aeschleman L, et al
    Notes from the Field: Clade II Mpox Surveillance Update - United States, October 2023-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:474-476.
    >> Share


    N Engl J Med

  55. GUAN L, Eisfeld AJ, Pattinson D, Gu C, et al
    Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMc2405495.
    >> Share

  56. RUBIN EJ, Baden LR, Daskalakis D, Marston H, et al
    Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
    N Engl J Med. 2024 May 22. doi: 10.1056/NEJMe2406224.
    >> Share

  57. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    >> Share


    PLoS Comput Biol

  58. TRINITY L, Stege U, Jabbari H
    Tying the knot: Unraveling the intricacies of the coronavirus frameshift pseudoknot.
    PLoS Comput Biol. 2024;20:e1011787.
    >> Share


    PLoS Med

  59. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    >> Share


    PLoS One

  60. QING W, Xuebo Z
    Rational resistance amidst gentle breeze and mild rain: Examining online collective behavior among the Chinese public using the elaborated social identity model.
    PLoS One. 2024;19:e0303603.
    >> Share

  61. ROBOTTO A, Olivero C, Pozzi E, Strumia C, et al
    Efficient wastewater sample filtration improves the detection of SARS-CoV-2 variants: An extensive analysis based on sequencing parameters.
    PLoS One. 2024;19:e0304158.
    >> Share

  62. NGOC BH, Hoang CC, Tram NHM
    A time-varying analysis between economic uncertainty and tourism development in Singapore.
    PLoS One. 2024;19:e0302980.
    >> Share

  63. LIU Y, Goh CH, Shen D, Qiu H, et al
    The incidence of thrombosis with co-occurring thrombocytopenia prior to the SARS-CoV2 pandemic: A population-based study.
    PLoS One. 2024;19:e0301359.
    >> Share

  64. CHEN J, Sun J, Wei S, You X, et al
    Does strategic coupling of TNCs affect their exit from host regions: Empirical analysis of the exit of Taiwanese enterprises from mainland China.
    PLoS One. 2024;19:e0304254.
    >> Share

  65. LLANOS N, Iglesias L, Galvez Espinoza P, Cuevas C, et al
    Food and family care during the COVID-19 pandemic: A study of women's domestic workload during the first wave in Chile.
    PLoS One. 2024;19:e0301038.
    >> Share

  66. ANDRADE GC, Caldeira TCM, Mais LA, Bortoletto Martins AP, et al
    Food price trends during the COVID-19 pandemic in Brazil.
    PLoS One. 2024;19:e0303777.
    >> Share

  67. APRININGSIH, Hanifah L, Nasrulloh N
    Exclusive breastfeeding practice during COVID-19 pandemic in West Java Indonesia: A cross-sectional study.
    PLoS One. 2024;19:e0303386.
    >> Share

  68. LAU WY, Ke GN, Yip TM, Wong RMM, et al
    Socioeconomic impact and sufficiency of government financial support during COVID-19 pandemic: A retrospective study.
    PLoS One. 2024;19:e0302979.
    >> Share

  69. KASZTELEWICZ B, Skrok K, Burzynska J, Migdal M, et al
    Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.
    PLoS One. 2024;19:e0301612.
    >> Share

  70. ITAM MF, Minhat HS, Abd Rahman A, Ibrahim MZ, et al
    The COVID-19 pandemic related stress and the associated factors among the healthcare workers in Kota Setar District Health Office, Malaysia.
    PLoS One. 2024;19:e0301469.
    >> Share

  71. ISHIGAKI Y, Yokogawa S
    Monitoring the ventilation of living spaces to assess the risk of airborne transmission of infection using a novel Pocket CO2 Logger to track carbon dioxide concentrations in Tokyo.
    PLoS One. 2024;19:e0303790.
    >> Share

  72. ALLO G, Sitarik AR, Redding A, Coleman CM, et al
    Maternal COVID-19 exposure and placental characteristics.
    PLoS One. 2024;19:e0302682.
    >> Share

  73. ROLDAN CJ, Prasetyo YT, Ong AKS, Ayuwati ID, et al
    Copywriters' preference evaluation on online copywriting course attributes during the COVID-19 pandemic.
    PLoS One. 2024;19:e0292467.
    >> Share

  74. LEWANDOWSKI ME, Delawalla CN, Butcher TJ, Oberlin BG, et al
    Changes in substance use, recovery, and quality of life during the initial phase of the COVID-19 pandemic.
    PLoS One. 2024;19:e0300848.
    >> Share

  75. LOOKER KJ, McClenaghan E, Judd A, Pierotti L, et al
    Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study.
    PLoS One. 2024;19:e0303892.
    >> Share

  76. YING X, Peng H, Xie J
    Big data analysis for Covid-19 in hospital information systems.
    PLoS One. 2024;19:e0294481.
    >> Share

  77. CHANG SC, Grunkemeier GL, Goldman JD, Wang M, et al
    A simplified pneumonia severity index (PSI) for clinical outcome prediction in COVID-19.
    PLoS One. 2024;19:e0303899.
    >> Share

  78. TASSANEEYASIN T, Sungkanuparph S, Srichatrapimuk S, Charoensri A, et al
    Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
    PLoS One. 2024;19:e0303995.
    >> Share

  79. BOOIJ-TROMP FM, van Groningen NJ, Vervuurt S, Haagsma JA, et al
    Association between stringency of lockdown measures and emergency department visits during the COVID-19 pandemic: A Dutch multicentre study.
    PLoS One. 2024;19:e0303859.
    >> Share

  80. QU Y, Lee CY
    Estimation of standardized real-time fatality rate for ongoing epidemics.
    PLoS One. 2024;19:e0303861.
    >> Share

  81. FUKUI N, Li SS, DeGuzman J, Myers JF, et al
    Mixed methods approach to examining the implementation experience of a phone-based survey for a SARS-CoV-2 test-negative case-control study in California.
    PLoS One. 2024;19:e0301070.
    >> Share

  82. OH AR, Kang ES, Park J, Lee SM, et al
    Does coronavirus disease 2019 history alone increase the risk of postoperative pulmonary complications after surgery? Prospective observational study using serology assessment.
    PLoS One. 2024;19:e0300782.
    >> Share

  83. PAUL O, Akolia IK, Qin Tao J, Jain N, et al
    Reactive oxygen species in endothelial signaling in COVID-19: Protective role of the novel peptide PIP-2.
    PLoS One. 2024;19:e0289854.
    >> Share

  84. SHARMA M, Sra H, Painter C, Pan-Ngum W, et al
    Cost-effectiveness analysis of surgical masks, N95 masks compared to wearing no mask for the prevention of COVID-19 among health care workers: Evidence from the public health care setting in India.
    PLoS One. 2024;19:e0299309.
    >> Share

  85. SUAIFAN GARY, Abu-Odeh AM, Shehadeh MB, Jbara FA, et al
    A cross-sectional study on adult lifestyle habits during the COVID-19 pandemic.
    PLoS One. 2024;19:e0299668.
    >> Share

  86. LEVANO DC, Lopez SE, Gherasim A, Dominguez JO, et al
    The Temporary Incapacity (TI) register as a complementary system to traditional epidemiological surveillance during the COVID-19 pandemic in Spain.
    PLoS One. 2024;19:e0301344.
    >> Share

  87. THANONGSAKSRIKUL J, Sritipsukho P, Srimanote P, Khantisitthiporn O, et al
    Characterization of antibody response to SARS-CoV-2 Orf8 from three waves of COVID-19 outbreak in Thailand.
    PLoS One. 2024;19:e0297272.
    >> Share

  88. LIU M, Yang W, Tian T, Yang J, et al
    Extreme value analysis of the number of student absences in Jiangsu, China: Based on extreme value theory.
    PLoS One. 2024;19:e0302360.
    >> Share

  89. HUAYTA VMR, Pradeilles R, Creed-Kanashiro HM, Rousham E, et al
    Identifying priority double-duty actions to tackle the double burden of malnutrition in infants and young children in Peru: Assessment and prioritisation of government actions by national experts.
    PLoS One. 2024;19:e0303668.
    >> Share

  90. JOHNSON KJ, O'Connell CP, Waken RJ, Barnes JM, et al
    Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    PLoS One. 2024;19:e0303280.
    >> Share


    Proc Natl Acad Sci U S A

  91. LICHAND G, Doria CA
    The lasting impacts of remote learning in the absence of remedial policies: Evidence from Brazil.
    Proc Natl Acad Sci U S A. 2024;121:e2316300121.
    >> Share

  92. LAL A, Thompson DM
    Did private election administration funding advantage Democrats in 2020?
    Proc Natl Acad Sci U S A. 2024;121:e2317563121.
    >> Share

  93. ENDEVELT K, Halperin E, Porat R
    Zoom out: An intervention on the virtual learning environment improves minority students' grades in two field experiments in Israel.
    Proc Natl Acad Sci U S A. 2024;121:e2313496121.
    >> Share

  94. MEI M, Cupic A, Miorin L, Ye C, et al
    Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2314166121.
    >> Share


    Vaccine

  95. BENEDICT KPOZEHOUEN E, Raina Macintyre C, Tan TC
    Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community.
    Vaccine. 2024 May 23:S0264-410X(24)00619-4. doi: 10.1016/j.vaccine.2024.
    >> Share

  96. EIBERG MF, Rezahosseini O, Bukan KB, Charlotte Arp B, et al
    Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis.
    Vaccine. 2024 May 23:S0264-410X(24)00566-8. doi: 10.1016/j.vaccine.2024.
    >> Share

  97. ZHANG WX, Zhang Y, Du J, Shi W, et al
    Effectiveness of momentary intervention on influenza vaccination among the elderly in China: From willingness to action.
    Vaccine. 2024 May 22:S0264-410X(24)00591-7. doi: 10.1016/j.vaccine.2024.
    >> Share

  98. VAN DER PLAS JL, Haijema BJ, Leenhouts K, Paul Zoeteweij J, et al
    Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (GEM) particles (FluGEM): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly.
    Vaccine. 2024 May 20:S0264-410X(24)00370-0. doi: 10.1016/j.vaccine.2024.
    >> Share

  99. YANG T, Tong F, Tang L, Li P, et al
    Repeated vaccination does not appear to significantly weaken the protective effect of influenza vaccine in the elderly: A test-negative case-control study in China.
    Vaccine. 2024 May 17:S0264-410X(24)00593-0. doi: 10.1016/j.vaccine.2024.
    >> Share

  100. HU H, Ma F, Gong L, Wang Y, et al
    Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults.
    Vaccine. 2024 May 3:S0264-410X(24)00495-X. doi: 10.1016/j.vaccine.2024.
    >> Share

  101. NIESSEN FA, Bruijning-Verhagen PCJL, Bonten MJM, Knol MJ, et al
    Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study.
    Vaccine. 2024 Apr 29:S0264-410X(24)00432-8. doi: 10.1016/j.vaccine.2024.
    >> Share

  102. GUDOORU K, Nguyen K, Le K, Sarabu V, et al
    Collective good and individual choice: Perceptions on COVID-19 vaccine mandate among COVID-19 vaccinated individuals.
    Vaccine. 2024 Apr 27:S0264-410X(24)00479-1. doi: 10.1016/j.vaccine.2024.
    >> Share

  103. LYTRAS T, Athanasiadou M, Demetriou A, Stylianou D, et al
    Authors' reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign.
    Vaccine. 2024 Apr 25:S0264-410X(24)00506-1. doi: 10.1016/j.vaccine.2024.
    >> Share

  104. FUJITA DM, da Silva Nali LH, da Costa RR, de Andrade Junior HF, et al
    Low vaccine coverage and varicella outbreaks in Brazil - 2019-2022.
    Vaccine. 2024 Apr 24:S0264-410X(24)00435-3. doi: 10.1016/j.vaccine.2024.
    >> Share

  105. SONG S, Madewell ZJ, Liu M, Miao Y, et al
    A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants.
    Vaccine. 2024 Apr 22:S0264-410X(24)00476-6. doi: 10.1016/j.vaccine.2024.
    >> Share

  106. MUSA S, Merdrignac L, Skocibusic S, Nedic R, et al
    BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study.
    Vaccine. 2024 Apr 20:S0264-410X(24)00471-7. doi: 10.1016/j.vaccine.2024.
    >> Share

  107. RICKE IJ, Spaulding AB, Rajtar NN, Benton EM, et al
    Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota.
    Vaccine. 2024 Apr 18:S0264-410X(24)00480-8. doi: 10.1016/j.vaccine.2024.
    >> Share

  108. ORANGZEB S, Desalegn A, Trinh NTH, Zhao J, et al
    COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals.
    Vaccine. 2024 Apr 18:S0264-410X(24)00464-X. doi: 10.1016/j.vaccine.2024.
    >> Share

  109. TRINITE B, Durr E, Pons-Grifols A, O'Donnell G, et al
    VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
    Vaccine. 2024 Apr 18:S0264-410X(24)00473-0. doi: 10.1016/j.vaccine.2024.
    >> Share

  110. KUPEK E
    Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023.
    Vaccine. 2024;42:3437-3444.
    >> Share

  111. ECONOMIDOU EC, Soteriades ES
    Excess mortality in Cyprus during the COVID-19 vaccination campaign.
    Vaccine. 2023 Nov 22:S0264-410X(23)01361-0. doi: 10.1016/j.vaccine.2023.
    >> Share

  112. BOLOTIN S, Osman S, Halperin S, Severini A, et al
    Immunity of Canadians and risk of epidemics workshop - Conference report.
    Vaccine. 2023;41:6775-6781.
    >> Share

  113. PARK H, Jang MS, Choi JA, Kim W, et al
    Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits.
    Vaccine. 2023 Oct 9:S0264-410X(23)01178-7. doi: 10.1016/j.vaccine.2023.
    >> Share

  114. MO C, Li X, Wu Q, Fan Y, et al
    SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses.
    Vaccine. 2023 Oct 9:S0264-410X(23)01156-8. doi: 10.1016/j.vaccine.2023.
    >> Share

  115. PROCTER TD, Ogasawara H, Spruin S, Wijayasri S, et al
    Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
    Vaccine. 2023 Oct 6:S0264-410X(23)01159-3. doi: 10.1016/j.vaccine.2023.
    >> Share

  116. DO LAH, Le NTN, Mahmud S, Mulholland K, et al
    Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study.
    Vaccine. 2023;41:6782-6790.
    >> Share


    Virus Res

  117. LIN X, Yang F, Yan S, Wu H, et al
    Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Virus Res. 2024;345:199402.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016